HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
Two scientists work in a lab

NCATS and FDA To Fund Rare Disease Studies

NCATS’ TRND program is supporting two natural history studies on how specific rare diseases progress over time.

A human brain tumor mass that has been engrafted into and is actively growing within a rat brain slice explant.

Collaboration Aims to Improve Brain Cancer Drug Testing

CTSA Program-supported scientists work to develop novel technique to test drugs against the most common form of brain cancer.

Person reading the newsletter on a tablet

September E-Newsletter Now Available

Read about a promising new gene therapy for a rare condition, CTSA Program-supported brain cancer drug testing, NIH’s latest awards for Tissue Chip research, and more.

A lung-on-a-chip

Tissue Chip Disease Modeling Awards

NCATS announced 13 awards to develop 3-D tissue chip research platforms that model disease and test drug efficacy prior to clinical trials.

Layers of nerve cells in the retina

October Biomedical Data Translator Meeting

Join NCATS on Oct. 25, 2017, to learn more about the progress being made on constructing the biomedical data translator.

More Center News

New Online Portal

NCATS launched an online resource portal to help patient support organizations

Gene Therapy Closer to Market

NCATS and Agilis researchers collaborated on a gene therapy for a rare pediatric condition

  • Facebook icon
  • Twitter icon
  • YouTube icon

Assay Guidance Manual

Assay Guidance Manual Cover

Interested in creating biologically, physiologically and pharmacologically relevant assays for early-stage drug discovery? Check out our best-practices Assay Guidance Manual.

Work with Us

Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.

  • NCATS Programs & Initiatives
    NCATS encourages partnerships that cross many scientific disciplines and research sectors in pursuit of translational success.
  • Small Business Opportunities
    NCATS’ small business programs help entrepreneurs develop and commercialize new translational technologies.
  • Expertise & Resources
    NCATS staff are experts in translation, and the Center’s resources support pre-clinical and clinical activities.
  • Licensing Opportunities
    NCATS makes it easy for industry and academia to interact and partner with Center laboratories and scientists.